You are currently viewing Artificial intelligence enhances ovarian cancer diagnostics

Artificial intelligence enhances ovarian cancer diagnostics

  • Post author:
  • Post last modified:November 10, 2022
  • Post comments:0 Comments

Ovarian cancer impacts over 3,100 Canadian women each year, making it the most lethal of all female reproductive cancers. A new study led by Dr. Ali Bashashati, a CVIA and Vancouver Coastal Health Research Institute researcher, reveals how artificial intelligence (AI) can aid in the diagnosis of ovarian cancer to improve patient outcomes.

The study, recently published in Modern Pathology, builds on the understanding that ovarian cancer is not a single disease, but several distinct subtypes, called histotypes.

Dr. Bashashati and his team compared ovarian cancer disease classifications made by an AI machine learning-based model against those of a team of expert gynecologic pathologists who specialize in the diagnosis of female reproductive cancers.

 

Using a cohort of 948 ovarian cancer tissue specimens from Vancouver General Hospital, Dr. Bashashati’s team developed a series of AI computer algorithms that can identify four histotypes of ovarian cancer with a high degree of accuracy.

Leave a Reply